Trial intelligence / Profile preview

Pregabalin versus cinnarizine for migraine prophylaxis in children

IRCT20230415057911N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in migraine comparing Pregabalin with Cinnarizine (2 arms). Primary endpoint: Frequency of migraine headaches. Started Jun 2021; status: completed.

02

Drugs

pregabalincinnarizine
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20230415057911N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230415057911N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call